RxDoctor Payments Data

Kimberly Rethy, DO

Otolaryngology · East Brunswick, NJNPI 1295150217

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,406 of the $2,789 with a category attached, or 86.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations.

$2,789in general payments, 2019–2025

Across 148 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$625
  • Optinose US, Inc.$566
  • Regeneron Healthcare Solutions, Inc.$432
  • Smith+Nephew$329
  • GSK$186
  • Kaleo, Inc.$126
  • plus $524 from 15 others

What the payments were for

  • Food & beverage$2,40686%
  • Education$38214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,789 in reported general payments places this provider in the 75th percentile of 232 otolaryngology providers in New Jersey.

See all otolaryngology providers in New Jersey

Medicare billing

Part B allowed, 2024
$163,693
Medicare patients
609
Services billed
1,501

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ipratropium Bromide64$2,863
Fluticasone Propionate168$2,365
Azelastine Hcl36$916
Mometasone Furoate17$871
Famotidine39$559
Ofloxacin22$551
Mupirocin48$283
Triamcinolone Acetonide36$201
Pantoprazole Sodium25$198
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$167
Prednisone48$112

Paid to pharmacies, not to this prescriber.

Other otolaryngology in East Brunswick

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →